Form4insider filings, from the source

SEC Form 4 · accession 0001104659-15-023568

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mary Z. Luo
Officer — COO, Chief Scientist, Chairman · Director · 10% Owner
Jack Y. Zhang
Officer — CEO & Chief Science Officer · Director · 10% Owner
Period of report
Mar 26, 2015
Accepted (ET)
Mar 30, 2015 · 6:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 26, 2015A125,418$0.00A932,513D
Common StockF1,F2Mar 26, 2015A53,511$0.00A670,307ISee footnote
Common StockF3holding———7,631,594ISee footnote
Common StockF4holding———5,000ISee footnote
Common StockF5holding———200,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F6$14.95Mar 26, 2015A767,912A—Mar 26, 2020Common Stock767,912767,912D
Employee Stock Option (right to buy)F2,F6$14.95Mar 26, 2015A327,647A—Mar 26, 2020Common Stock327,647327,647I

Explanation of responses